Stay updated on Elsubrutinib & Upadacitinib in SLE Clinical Trial

Sign up to get notified when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elsubrutinib & Upadacitinib in SLE Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, while also removing specific location details such as state, country, and city information.
    Difference
    51%
    Check dated 2025-08-30T11:55:37.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T04:51:19.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11.
    Difference
    0.3%
    Check dated 2025-08-09T00:19:55.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-01T19:34:55.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.
    Difference
    0.8%
    Check dated 2025-07-25T15:13:15.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.3%
    Check dated 2025-07-18T11:57:09.000Z thumbnail image

Stay in the know with updates to Elsubrutinib & Upadacitinib in SLE Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elsubrutinib & Upadacitinib in SLE Clinical Trial page.